← Leaderboards
Hoau-Yan Wang
Thomas Jefferson University
$1,895,662
Attributed
$4,409,734
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2017–23$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,409,734 · 3
By mechanism
R01$2,554,501 · 1
R44$1,559,890 · 1
R42$295,343 · 1
Top collaborators
- Chang-Gyu Hahn4 shared
- Lindsay H Burns3 shared
- George Ben Thornton3 shared
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Chang-Gyu Hahn$12,209,588
- Paul A Janmey$17,822,534
- Sandor S Shapiro$1,208,304
- Kerry S Campbell$9,648,609
- Matthew B Dalva$15,589,714
Others in their field
Other Emerging Leaders on “Tissues”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Kevin Urdahl · Seattle Children'S Hospital$84,741,409
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$61,115,130
- Leonard Freedman · Leidos Biomedical Research, Inc.$54,559,980
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Evan Z Macosko · Broad Institute, Inc.$33,867,067
Research focus
TissuesS DiseaseBrainAutopsyAlzheimer&AposBaseLeadAlgorithmsAffinityChromatinAntigensArchivesAtac-SeqAttenuatedAntibody FormationAlpha-Bungarotoxin ReceptorBrain RegionBindingAntibodiesBlindedBloodAmyloid Beta-ProteinAttenuationAlleles
Grant awards (7)
mGluR5 hypoactivity is integral to glutamatergic dysregulation in schizophrenia$609,276
R01 · FY2023 · MH
mGluR5 hypoactivity is integral to glutamatergic dysregulation in schizophrenia$609,276
R01 · FY2022 · MH
mGluR5 hypoactivity is integral to glutamatergic dysregulation in schizophrenia$647,997
R01 · FY2021 · MH
Development of PTI-125-DX, a blood-based diagnostic for Alzheimer's disease$450,142
R44 · FY2020 · AG
Development of PTI-125-DX, a blood-based diagnostic for Alzheimer's disease$1,109,748
R44 · FY2019 · AG
mGluR5 hypoactivity is integral to glutamatergic dysregulation in schizophrenia$687,952
R01 · FY2019 · MH
Development of PTI-125-DX, a blood-based diagnostic for Alzheimer's disease$295,343
R42 · FY2017 · AG